Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease.

Abstract	Tc-99m hydroxymethylene disphosphonate administered for skeletal scintigraphy may be seen in the extraosseous tissues for various etiologies. This report presents similar abnormal lower extremity skeletal muscle uptake in 2 patients status postorthotopic liver transplant. Although the history and scintigraphic appearance of the 2 were similar, subtle differences in cutaneous lesions and histology led to disparate diagnoses.
Authors	Jeffrey M Gremmels, Gerald A Kirk
Journal	Clinical nuclear medicine (Clin Nucl Med) Vol. 29 Issue 11 Pg. 694-7 (Nov 2004) ISSN: 0363-9762 [Print] United States
PMID	15483480 (Publication Type: Case Reports, Journal Article)
Chemical References	Radiopharmaceuticals technetium Tc 99m hydroxymethylene diphosphonate Technetium Tc 99m Medronate
Topics	Fibrosis Graft vs Host Disease (diagnostic imaging) Humans Kidney Diseases (diagnostic imaging) Liver Transplantation Male Middle Aged Muscle, Skeletal (diagnostic imaging) Radionuclide Imaging Radiopharmaceuticals Skin Diseases (diagnostic imaging) Technetium Tc 99m Medronate (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!